金城医药

- 300233

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
金城医药(300233) 利润表
单位:万元
报表日期2024-06-302024-03-312023-12-312023-09-302023-06-30
一、营业总收入175,857.8393,169.66353,831.25256,875.27170,529.33
营业收入175,857.8393,169.66353,831.25256,875.27170,529.33
二、营业总成本160,445.0582,459.80329,366.78238,674.95157,048.33
营业成本104,427.3551,710.40199,112.71148,123.7496,972.10
营业税金及附加2,019.841,041.893,615.522,809.721,830.52
销售费用27,804.9217,186.2268,064.7648,983.9831,556.57
管理费用18,234.558,803.9439,075.0825,645.9518,425.30
财务费用-199.64-54.161,027.86929.25643.42
研发费用8,158.023,771.5118,470.8512,182.327,620.42
资产减值损失----------
公允价值变动收益46.4420.31-8.15-1.34-26.45
投资收益-217.16-16.4359.01-7.04-33.31
其中:对联营企业和合营企业的投资收益-48.14-31.57-73.05-24.38-15.69
汇兑收益----------
三、营业利润16,277.1311,564.9622,584.9217,551.6313,417.42
加:营业外收入155.437.1998.4077.3572.60
减:营业外支出32.5816.67142.56-1.15-79.22
其中:非流动资产处置损失----------
四、利润总额16,399.9811,555.4822,540.7517,630.1413,569.24
减:所得税费用2,503.742,639.583,209.652,964.642,491.98
五、净利润13,896.258,915.8919,331.1014,665.5011,077.26
归属于母公司所有者的净利润13,059.168,297.1317,470.9413,248.0410,170.94
少数股东损益837.09618.761,860.161,417.47906.31
六、每股收益
基本每股收益(元/股)0.34000.22000.45000.34000.2600
稀释每股收益(元/股)0.34000.22000.45000.34000.2600
七、其他综合收益----170.52705.67705.67
八、综合收益总额13,896.258,915.8919,501.6215,371.1711,782.92
归属于母公司所有者的综合收益总额13,059.168,297.1317,641.4613,953.7010,876.61
归属于少数股东的综合收益总额837.09618.761,860.161,417.47906.31
下载全部历史数据到excel中 返回页顶